CA2668741A1 - Method for the production of an agent against an infectious disease - Google Patents
Method for the production of an agent against an infectious disease Download PDFInfo
- Publication number
- CA2668741A1 CA2668741A1 CA002668741A CA2668741A CA2668741A1 CA 2668741 A1 CA2668741 A1 CA 2668741A1 CA 002668741 A CA002668741 A CA 002668741A CA 2668741 A CA2668741 A CA 2668741A CA 2668741 A1 CA2668741 A1 CA 2668741A1
- Authority
- CA
- Canada
- Prior art keywords
- extract
- solution
- infectious disease
- ebola
- atmospheres
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 17
- 208000035473 Communicable disease Diseases 0.000 title claims abstract description 10
- 208000015181 infectious disease Diseases 0.000 title claims abstract description 10
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 7
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 15
- 239000001301 oxygen Substances 0.000 claims abstract description 15
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 14
- 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims description 9
- 241000218206 Ranunculus Species 0.000 claims description 7
- 239000012153 distilled water Substances 0.000 claims description 7
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 6
- 229910052749 magnesium Inorganic materials 0.000 claims description 6
- 239000011777 magnesium Substances 0.000 claims description 6
- 235000000346 sugar Nutrition 0.000 claims description 6
- 241000195493 Cryptophyta Species 0.000 claims description 5
- 241001327634 Agaricus blazei Species 0.000 claims description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- 235000011197 perejil Nutrition 0.000 claims description 3
- 241000196324 Embryophyta Species 0.000 claims description 2
- 244000141009 Hypericum perforatum Species 0.000 claims description 2
- 235000017309 Hypericum perforatum Nutrition 0.000 claims description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 2
- 241000218201 Ranunculaceae Species 0.000 claims description 2
- 239000000470 constituent Substances 0.000 claims description 2
- 229910052744 lithium Inorganic materials 0.000 claims description 2
- 241000208317 Petroselinum Species 0.000 claims 2
- 235000020759 St. John’s wort extract Nutrition 0.000 claims 1
- 229940099416 st. john's wort extract Drugs 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 14
- 241000725303 Human immunodeficiency virus Species 0.000 description 8
- 230000000694 effects Effects 0.000 description 4
- 241000233866 Fungi Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000013043 chemical agent Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 210000002443 helper t lymphocyte Anatomy 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 235000021119 whey protein Nutrition 0.000 description 2
- 241000222518 Agaricus Species 0.000 description 1
- 240000007440 Agaricus campestris Species 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 240000009164 Petroselinum crispum Species 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000002361 compost Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000002664 inhalation therapy Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000002926 oxygen Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006052504.3 | 2006-11-06 | ||
| DE102006052504A DE102006052504A1 (de) | 2006-11-06 | 2006-11-06 | Verfahren zum Herstellen eines Mittels gegen eine Infektionskrankheit |
| PCT/EP2007/009490 WO2008055620A2 (de) | 2006-11-06 | 2007-10-31 | Verfahren zum herstellen eines mittels gegen eine infektionskrankheit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2668741A1 true CA2668741A1 (en) | 2008-05-15 |
Family
ID=39114577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002668741A Abandoned CA2668741A1 (en) | 2006-11-06 | 2007-10-31 | Method for the production of an agent against an infectious disease |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20100021556A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2089043A2 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2010508367A (cg-RX-API-DMAC10.html) |
| CN (1) | CN101686999A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2668741A1 (cg-RX-API-DMAC10.html) |
| DE (1) | DE102006052504A1 (cg-RX-API-DMAC10.html) |
| RU (1) | RU2009118361A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2008055620A2 (cg-RX-API-DMAC10.html) |
| ZA (1) | ZA200903936B (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8551535B1 (en) | 2012-08-06 | 2013-10-08 | Sarah McCann | Homeopathic remedies and methods for enhancing weight loss |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3936355A (en) * | 1973-11-12 | 1976-02-03 | The Regents Of The University Of California | Microorganism growth media and the stabilization thereof |
| GB2135668B (en) * | 1982-12-25 | 1986-08-13 | Takara Shuzo Co | Of4949, a physiologically active substance and derivatives thereof |
| US5456924A (en) | 1988-12-23 | 1995-10-10 | Immunotec Research Corporation Ltd. | Method of treatment of HIV-seropositive individuals with dietary whey proteins |
| GB9807781D0 (en) | 1998-04-09 | 1998-06-10 | Univ Bristol | Therapeutic agent |
| US6143780A (en) * | 1999-09-17 | 2000-11-07 | Uniroyal Chemical Company, Inc. | N-arylmethylthioanilide compounds useful for the inhibition of the replication of HIV |
| JP2002218969A (ja) * | 2001-01-26 | 2002-08-06 | Tsukuba Bio Syst:Kk | 食用菌の製造方法 |
| ITMI20011633A1 (it) * | 2001-07-27 | 2003-01-27 | San Raffaele Centro Fond | Uso di polisaccaridi batterici supersolfatati inibitori dell'hiv |
-
2006
- 2006-11-06 DE DE102006052504A patent/DE102006052504A1/de not_active Withdrawn
-
2007
- 2007-10-31 ZA ZA200903936A patent/ZA200903936B/xx unknown
- 2007-10-31 RU RU2009118361/15A patent/RU2009118361A/ru unknown
- 2007-10-31 WO PCT/EP2007/009490 patent/WO2008055620A2/de not_active Ceased
- 2007-10-31 EP EP07819519A patent/EP2089043A2/de not_active Ceased
- 2007-10-31 CN CN200780049262A patent/CN101686999A/zh active Pending
- 2007-10-31 CA CA002668741A patent/CA2668741A1/en not_active Abandoned
- 2007-10-31 JP JP2009535608A patent/JP2010508367A/ja active Pending
- 2007-10-31 US US12/513,674 patent/US20100021556A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2089043A2 (de) | 2009-08-19 |
| US20100021556A1 (en) | 2010-01-28 |
| CN101686999A (zh) | 2010-03-31 |
| JP2010508367A (ja) | 2010-03-18 |
| RU2009118361A (ru) | 2010-12-20 |
| WO2008055620A3 (de) | 2009-03-05 |
| ZA200903936B (en) | 2010-08-25 |
| WO2008055620A2 (de) | 2008-05-15 |
| DE102006052504A1 (de) | 2008-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10117910B2 (en) | Composition of natural vitamin C and fish scale collagen peptide and preparation method thereof | |
| US20090110674A1 (en) | Health supplement | |
| WO2005000245A3 (en) | Compositions and methods for increasing telomerase activity | |
| TW201536341A (zh) | 紅藜萃取物用於製備促進膠原蛋白生成及抗皮膚老化之組合物之用途 | |
| KR20130029098A (ko) | 누에와 뽕나무잎과 상지(桑枝)를 이용한 이온미네랄 제조방법 및 이에 의해 제조 된 건강음료 | |
| Hamidpour et al. | Chemistry, pharmacology and medicinal property of Russian olive (Elaeagnus angustifolia L.) | |
| CN102440386A (zh) | 一种全复合人体抗氧化剂 | |
| CN104096047A (zh) | 一种治疗毒蛇咬伤的外敷解毒软膏及其制备方法 | |
| US20100021556A1 (en) | Method for the Production of an Agent Against an Infectious Disease | |
| JPH1075750A (ja) | にんにく系健康飲料 | |
| CN109645494A (zh) | 改善人体机能和预防心脑血管疾病的组合物及制备方法 | |
| CN105233250B (zh) | 一种用于治疗脑病的复合生物制剂 | |
| CN114931611A (zh) | 一种治疗烧烫伤、创伤病症的中药组合物及其制备方法 | |
| CN101554374B (zh) | 具有二肽基肽酶iv抑制作用的黄酮类化合物 | |
| CN107094877A (zh) | 一种大米复合保鲜剂 | |
| CN108187032A (zh) | 虫草胶原蛋白肽片 | |
| CN106166165A (zh) | 一种有效提高多种临床相关疾病治疗效果的美洲大蠊药物组合物及其制备方法 | |
| US20210000783A1 (en) | Use of extract of vegetation waters for treating damage to the cardiovascular system | |
| US20210023127A1 (en) | Method to extract a pharmaceutical composition from a therapeutic compound | |
| KR101115041B1 (ko) | 계육 가수분해물을 포함하는 기능성 조성물 및 이의 제조방법 | |
| Korro et al. | PRIMARY DATA ON REDUCTION OF CONSEQUENCES OF COVID-19 THROUGH THE USE OF PROPOLIS IN ALBANIAN PATIENTS | |
| CN1686343A (zh) | 一种抗菌生肌的中药制剂 | |
| CN1899357B (zh) | 柿子霜药品的生产方法 | |
| CN107184690B (zh) | 具有抗炎作用的鸡矢藤-葫芦茶组合物及其制备方法和应用 | |
| CN120570875A (zh) | 一种肽-镁复合物及其制备方法与应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |
Effective date: 20141031 |